Photocure ASA (LON:0IMT)

Market Cap	104.05M
Revenue (ttm)	37.72M
Net Income (ttm)	-384.64K
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	98.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	505
Average Volume	555
Open	53.90
Previous Close	n/a
Day's Range	53.90 - 54.50
52-Week Range	48.00 - 69.80
Beta	0.78
RSI	35.61
Earnings Date	Oct 29, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Employees: 101
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IMT

Financial Performance

Financial numbers in NOK